FSGS (DBCOND0048223)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05505500	Interview Study of Adult and Child Patients and Parents of Children with Swelling Due to Nephrotic Syndrome.	No drug interventions	Not Available	Not Available	recruiting
NCT05383547	Bortezomib for Treating Glomerular Diseases	Bortezomib	treatment	Not Available	unknown_status
NCT01164098	Rituximab to Prevent Recurrence of Proteinuria	Rituximab	treatment	3	terminated
NCT01468493	A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients	No drug interventions	Not Available	Not Available	unknown_status
NCT05508009	Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor	Cyclophosphamide Fludarabine Melphalan Rituximab	treatment	1 / 2	recruiting
NCT05650619	Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease	No drug interventions	Not Available	Not Available	recruiting
NCT04571658	NEPTUNE Match Study	No drug interventions	Not Available	Not Available	enrolling_by_invitation
NCT01451489	The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis	Cyclophosphamide Tacrolimus	treatment	Not Available	terminated
NCT02683889	Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation	Corticotropin	prevention	3	active_not_recruiting
NCT03536754	A Study of CCX140-B in Subjects With FSGS	Ilacirnon	treatment	2	completed
NCT02399462	Acthar for Treatment of Post-transplant FSGS	Corticotropin	treatment	4	withdrawn
NCT04009668	Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease	Adalimumab	basic_science	2	completed
NCT05183646	A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB	Propagermanium	treatment	3	recruiting